Investigación en Enfermidades Hematolóxicas
Heinrich Heine University Düsseldorf
Düsseldorf, AlemaniaPublications in collaboration with researchers from Heinrich Heine University Düsseldorf (1)
2023
-
Assessment of joint bleeding and target joints in patients with severe or moderately severe hemophilia B (factor IX ≤2%) receiving prophylaxis with rIX-FP in the PROLONG-9FP clinical trial program
European Journal of Haematology, Vol. 111, Núm. 2, pp. 293-299